Related Experiment Video

Updated: Feb 23, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis

Mohammed Elmujtba Adam Essa1,2, Hamid Noori3, James Butler4

  • 1Department of clinical Medicine, Medical and Cancer Research Institute, Nyala, Sudan. Awadali818@yahoo.com.

BMC Cancer
|February 21, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AkkermansiaFaecalibacteriumNSCLCgut microbiomeimmune checkpoint inhibitorsmelanoma

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.6K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K